type
interferon
ifni
exert
pleiotrop
biolog
effect
viral
infect
contribut
balanc
viru
control
immun
patholog
despit
extens
antivir
function
subdu
viru
replic
recent
studi
demonstr
pathogen
provir
role
ifni
signal
acut
persist
viru
infect
ifni
signal
promot
morbid
mortal
induct
aberr
inflammatori
respons
acut
viral
infect
contrast
ifni
signal
persist
viral
infect
support
immun
suppress
lymphoid
tissu
disorgan
cell
dysfunct
systemat
character
cellular
popul
intricaci
ifni
signal
promot
patholog
immun
suppress
acut
persist
viral
infect
respect
inform
develop
treatment
modal
control
viral
associ
patholog
discov
abil
inhibit
influenza
viru
replic
cell
cultur
ifni
sinc
shown
potent
antivir
antiprolif
immun
modulatori
effect
ifni
famili
compris
function
gene
sever
subtyp
includ
ifni
subtyp
signal
common
receptor
pair
lead
induct
activ
follow
ifnregulatori
factor
activ
transcript
factor
trigger
induct
hundr
ifnstimulatori
gene
isg
restrict
viral
replic
variou
mechan
addit
ifni
signal
activ
stat
transcript
factor
defin
cellular
subset
includ
diversifi
downstream
gene
activ
signal
ifn
receptor
also
trigger
activ
nonstat
transcript
factor
instanc
ifni
signal
demonstr
activ
domain
contain
crk
protein
crkl
associ
tyrosin
phosphoryl
respons
treatment
turn
ifnimedi
crkl
activ
result
subsequ
activ
gtpase
regul
cell
differenti
prolifer
ifni
signal
also
activ
kinas
mapk
pathway
fact
ifni
signal
activ
associ
induct
interferon
stimul
respons
element
gene
isr
independ
activ
ifnidepend
activ
appear
requir
small
gtpase
follow
phosphoryl
end
result
mapk
activ
induct
isg
well
inhibit
cell
growth
signal
also
shown
activ
phosphatidylinositol
pathway
stimul
trigger
activ
catalyt
subunit
insulin
receptor
substrat
depend
statindepend
manner
induct
signal
pathway
ifni
signal
mediat
pro
antiapoptot
pathway
depend
cellular
subset
target
ifni
activ
also
activ
mammalian
target
rapamycin
mtor
postul
mobil
translat
machineri
downstream
pathway
activ
ifni
signal
depend
heavili
concentr
cellular
context
variou
ifni
subset
present
howev
divers
ifn
subset
differenti
exert
effect
associ
ifni
signal
instanc
specif
subset
ifn
differenti
stimul
antivir
antiprolif
activ
differ
bind
rate
affin
thought
occur
differenti
bind
receptor
subunit
ligandinduc
conform
chang
thu
ifni
signal
regul
antivir
immun
modulatori
respons
cellular
concentr
ifn
subset
specif
level
aspect
ifni
signal
control
cellular
respons
must
taken
account
studi
crucial
signal
pathway
viral
infect
addit
directli
inhibit
viru
propag
ifni
also
potent
immun
modulatori
function
ifni
promot
upregul
mhci
express
variou
cell
popul
requir
optim
cell
stimul
differenti
expans
kill
virusinfect
cell
autocrin
signal
ifni
dendrit
cell
promot
activ
cell
stimulatori
capac
ifni
signal
viru
infect
promot
convers
pdc
myeloid
deriv
dc
impair
hematopoiet
differenti
bone
marrow
progenitor
dc
metallophil
macrophag
demonstr
induc
express
protein
prevent
phosphoryl
inhibit
ifni
signal
cell
turn
repress
ifni
signal
allow
restrict
viru
replic
macrophag
promot
induct
antivir
adapt
immun
respons
ifni
also
exert
potent
costimulatori
effect
cell
enhanc
cell
prolifer
upon
cell
intrins
signal
time
ifni
exposur
cell
significantli
influenc
cell
differenti
magnitud
respons
exposur
cell
apc
ifni
prior
antigen
stimul
promot
mainten
phenotyp
reduc
prolifer
despit
product
effector
cytokin
direct
ifni
signal
memori
cell
induc
rapid
apoptosi
inhibit
prolifer
promot
earli
effector
differenti
memori
cell
upon
exposur
blockad
ifni
signal
wnv
infect
signific
effect
cell
expans
cytokin
product
differenti
administ
matur
phase
cell
respons
howev
effect
given
prior
infect
preval
viral
protein
specif
function
gear
toward
prevent
ifni
product
andor
signal
highlight
import
cytokin
control
viru
propag
howev
despit
product
virusderiv
ifni
regulatori
protein
robust
ifni
product
elev
ifni
signatur
observ
mani
viral
infect
thu
ifni
produc
potenti
influenc
mani
aspect
viru
control
immun
modul
infect
predomin
theme
acut
viru
infect
anim
model
delet
downstream
ifni
signal
pathway
increas
viru
replic
dissemin
lethal
explor
use
neutral
antibodi
wnv
infect
determin
essenti
curb
viral
propag
restrict
viral
pathogenesi
mice
display
enhanc
patholog
mortal
reduc
viru
control
sarscov
influenza
viru
infect
interestingli
ko
mice
mirror
enhanc
viral
load
patholog
consequ
observ
mice
sarscov
infect
suggest
pathway
necessari
control
sarscov
vivo
howev
infect
coronaviru
mous
hepat
viru
mhv
pdc
deriv
ifni
product
essenti
control
viru
replic
prevent
mortal
suggest
role
ifni
product
signal
control
viru
infect
vari
dramat
even
within
viral
famili
delet
ifni
relat
signal
pathway
respiratori
viru
infect
divers
effect
depend
viru
strain
anim
genet
background
human
null
mutat
interferon
regulatori
gene
result
reduc
ifni
iii
product
myeloid
pdc
suffer
lifethreaten
season
influenza
viru
infect
exposur
bone
marrow
cell
ifni
prior
recruit
lung
endow
cell
antivir
program
protect
viru
infect
upon
reach
infect
lung
delet
gene
mice
function
gene
increas
viru
replic
reduc
ld
infect
ko
mice
low
dose
mous
adapt
influenza
virus
result
increas
mortal
elev
viral
load
exacerb
lung
patholog
reduc
number
produc
cell
compar
control
moreov
exogen
administr
defici
anim
follow
influenza
viru
infect
partial
restor
surviv
amelior
lung
patholog
thu
ifni
protect
influenza
viru
infect
either
suppress
viru
spread
prompt
induct
immun
suppress
cytokin
quell
detriment
inflammatori
respons
addit
protect
effect
ifni
signal
pathogen
role
ifni
report
influenza
viru
infect
symptom
onset
experiment
influenza
viru
infect
human
correl
directli
local
appear
lavag
fluid
product
sever
proinflammatori
cytokin
chemokin
amplifi
signal
recent
report
delet
receptor
deplet
plasmacytoid
dendrit
cell
pdc
mice
inhibit
pulmonari
patholog
improv
surviv
follow
lethal
influenza
viru
challeng
moreov
treatment
influenza
viru
infect
mice
result
enhanc
morbid
mortal
thu
ifni
promot
patholog
consequ
acut
viru
influenza
viru
infect
laboratori
also
recent
identifi
treatment
sphingosin
phosphat
analog
earli
influenza
viru
infect
mice
result
reduc
morbid
mortal
lipid
metabolit
synthes
ceramid
precursor
sphingosin
sphingosin
subsequ
phosphoryl
sphingosin
kinas
sphk
bioactiv
level
bioactiv
stringent
regul
action
lyas
phosphatas
degrad
dephosphoryl
respect
highest
level
found
blood
lymph
significantli
lower
level
maintain
peripher
tissu
bind
signal
five
gprotein
coupl
receptor
denot
express
receptor
heterogen
found
hematopoiet
nonhematopoiet
lineag
function
coupl
multipl
heterotrimer
gprotein
promot
divers
cellular
function
associ
receptor
signal
signal
five
receptor
known
modul
multipl
cellular
function
includ
cell
adhes
migrat
surviv
prolifer
endocytosi
barrier
function
cytokin
product
recent
identifi
novel
regulatori
function
signal
blunt
earli
cytokin
innat
immun
cell
amplif
follow
influenza
viru
infect
earli
administr
promiscu
agonist
aalr
agonist
significantli
blunt
product
multipl
proinflammatori
cytokin
chemokin
follow
infect
either
wsn
human
pandem
influenza
viru
agon
blunt
amplif
follow
influenza
viru
infect
howev
mechan
current
unknown
howev
noteworthi
report
ifni
productionsign
modul
expressionact
upregul
promot
intern
cell
aalr
mediat
reduct
earli
innat
immun
cell
recruit
cytokinechemokin
product
correl
directli
reduc
lung
patholog
improv
surviv
influenza
viru
infect
agonist
clearli
inhibit
innat
immun
respons
signific
inhibit
activ
cell
recruit
lung
variou
time
post
infect
also
observ
mous
adapt
human
pathogen
strain
influenza
viru
find
extend
use
genet
chemic
tool
probe
function
receptor
gfp
knockin
transgen
mice
receptor
agonist
antagonist
reveal
pulmonari
endotheli
cell
modul
innat
immun
cell
recruit
cytokinechemokin
respons
earli
follow
influenza
viru
infect
importantli
agonist
treatment
blunt
cytokinechemokin
product
innat
immun
cell
recruit
lung
independ
endosom
cytosol
innat
sens
pathway
signal
suppress
cytokin
amplif
independ
multipl
innat
signal
adaptor
pathway
requir
adaptor
cytokin
amplif
follow
influenza
viru
challeng
immun
cell
infiltr
cytokin
product
found
distinct
event
orchestr
signal
suppress
earli
innat
immun
respons
signal
also
reduc
mortal
infect
human
pathogen
strain
swine
influenza
viru
ferret
model
demonstr
blunt
influenza
viru
pathogenesi
mice
could
extend
model
close
resembl
human
diseas
collect
result
suggest
blunt
global
cytokin
chemokin
product
innat
immun
cell
recruit
like
requir
effect
host
protect
excess
immunopatholog
importantli
demonstr
blunt
ifni
product
signal
accomplish
without
enhanc
viru
propag
follow
influenza
viru
infect
thu
studi
suggest
modul
influenza
viru
pathogenesi
blunt
ifni
signal
possibl
without
significantli
compromis
host
protect
respons
persist
viral
infect
chronic
immun
activ
neg
immun
regul
express
elev
interferon
signatur
lymphoid
tissu
destruct
correl
diseas
progress
elev
ifni
signatur
observ
lcmv
infect
mice
hiv
hcv
infect
human
nonhuman
primat
chronic
immun
activ
follow
hiv
infect
report
suppress
hyperactiv
state
propos
allevi
hiv
associ
patholog
diseas
follow
experiment
siv
infect
rhesu
macaqu
correl
elev
ifni
product
inflammatori
signatur
contrast
siv
infect
sooti
mangabey
african
green
monkey
develop
modest
patholog
despit
equival
viral
load
macaqu
correl
reduc
ifni
inflammatori
gene
express
similar
correl
respect
reduc
immun
activ
exist
hiv
infect
elit
control
although
whether
reduc
immun
activ
follow
viru
control
uncertain
blockad
signal
chronic
siv
infect
reduc
hyperimmun
activ
microbi
transloc
rhesu
macaqu
lower
ifni
signatur
blood
colon
moreov
elev
interferon
signatur
observ
hcvinfect
patient
despit
limit
control
viru
replic
develop
liver
patholog
fact
hcv
infect
cultur
block
isg
protein
express
activ
rnadepend
protein
kinas
creat
paradox
ifnidepend
viral
advantag
thu
ifni
signal
pathway
potenti
aid
viral
fit
promot
patholog
persist
viral
infect
studi
highlight
ifni
signal
system
viabl
target
help
control
persist
viral
infect
literatur
suggest
caus
role
ifni
contribut
pathogenesi
persist
viru
infect
definit
studi
perform
recent
assess
ifni
neutral
affect
outcom
viru
persist
laboratori
david
brook
assess
role
ifni
signal
play
persist
infect
use
persist
lcmv
strain
demonstr
blockad
ifni
signal
use
neutral
antibodi
reduc
immun
system
activ
decreas
express
neg
immun
regulatori
molecul
restor
lymphoid
architectur
mice
persist
infect
lcmv
blockad
prior
follow
establish
persist
lcmv
infect
promot
faster
viru
clearanc
requir
intact
tcell
compart
blockad
ifni
signal
appear
significantli
affect
cell
differenti
studi
demonstr
first
time
direct
causal
link
ifni
signal
immun
activ
neg
immun
regul
express
lymphoid
tissu
disorgan
viru
persist
recent
report
lcmv
persist
influenc
signal
treatment
mice
infect
lcmv
neutral
antibodi
hasten
viru
clearanc
compar
polyclon
antibodi
neutral
exacerb
earli
viru
replic
improv
lymphoid
architectur
enhanc
viru
specif
cell
respons
howev
neutral
clearli
promot
faster
viru
clearanc
compar
block
contribut
speci
neutral
polyclon
antibodi
use
determin
nevertheless
studi
suggest
neutral
may
promot
viru
control
without
significantli
affect
viru
replic
fact
recent
report
signal
depend
bind
independ
moreov
delet
amelior
lpsinduc
sepsi
induct
mice
unaffect
report
demonstr
differenti
modul
immun
respons
variou
diseas
state
highlight
import
futur
investig
understand
differ
ifni
speci
modul
diseas
pathogenesi
contrast
studi
report
treatment
mice
ifni
earli
stage
persist
lcmv
infect
promot
rapid
viru
control
mechanist
ifni
therapi
increas
expans
virusspecif
cell
prevent
cell
exhaust
howev
whether
due
ifni
mediat
immun
stimulatori
effect
lower
antigen
level
systemat
address
moreov
separ
studi
report
delet
oligoadenyl
synthetaselik
gene
prior
persist
lcmv
infect
facilit
sustain
ifni
product
signal
promot
cell
expans
reduc
cell
exhaust
promot
rapid
viru
control
likewis
ifni
administr
exert
protect
effect
slow
siv
replic
diseas
progress
administ
earli
follow
infect
shown
efficaci
hiv
infect
patient
moreov
treatment
pegyl
conjunct
antivir
drug
ribavirin
standard
care
treatment
patient
chronic
hepat
c
viru
hcv
infect
recent
howev
despit
success
hcv
therapi
optim
effect
administr
requir
ribavirin
even
combin
patient
respond
therapi
moreov
patient
fail
control
hcv
follow
ifni
therapi
higher
ifni
gene
signatur
prior
treatment
similar
trend
observ
follow
ifni
administr
hiv
siv
infect
ifni
administr
modest
effect
given
alreadi
establish
persist
infect
reason
discrep
observ
human
persist
viral
infect
ifni
therapi
promot
control
hcv
patient
other
establish
hiv
infect
minim
benefit
observ
interest
postul
one
could
imagin
scenario
persist
infect
hcv
patient
elev
ifni
signatur
persist
addit
pegyl
provid
minim
benefit
whether
treatment
pegyl
earlier
infect
prior
sustain
ifni
signatur
would
benefici
would
interest
know
similar
profil
appear
exist
persist
siv
infect
earli
administr
ifni
help
control
viral
load
pathogenesi
later
administr
modest
effect
viral
titer
diseas
outcom
taken
togeth
ifni
therapi
may
benefici
earli
stage
persist
viru
infect
infect
lower
ifni
signatur
howev
block
ifni
signal
either
alon
conjunct
antivir
therapi
may
prove
effect
viru
persist
elev
ifni
signatur
establish
figur
howev
ultim
outcom
like
depend
persist
viru
studi
genet
suscept
individu
subtyp
time
ifni
speci
produc
requir
investig
viral
infect
repres
signific
public
health
problem
across
globe
despit
concert
effort
develop
treatment
quell
viral
diseas
treatment
reduc
accompani
patholog
allow
host
purg
viru
met
limit
success
thu
larg
unmet
medic
need
exist
therapi
help
control
diseas
associ
viral
infect
recent
studi
describ
reveal
unexpect
pathogen
provir
role
ifni
signal
acut
persist
viru
infect
tabl
infus
new
hope
target
ifni
pathway
amelior
viral
diseas
futur
systemat
studi
focus
ifni
signal
regul
viral
replic
detriment
immun
respons
provid
valuabl
insight
effect
way
target
crucial
signal
pathway
sever
import
question
still
remain
provid
excit
avenu
futur
investig
role
ifni
signal
viral
infect
although
ifni
signal
trigger
variou
downstream
pathway
signal
individu
pathway
dictat
specif
outcom
follow
viral
infect
remain
incomplet
understood
moreov
role
individu
ifni
subset
play
restrain
viral
replic
promot
immun
inflammatorysuppress
program
vivo
requir
studi
context
immun
suppress
program
elicit
ifni
signal
persist
viru
infect
recent
demonstr
blockad
enhanc
viru
control
exacerb
earli
viru
replic
improv
lymphoid
architectur
enhanc
viru
specif
cell
respons
suggest
target
select
ifni
speci
redirect
immun
respons
suffici
promot
hasten
viru
control
employ
similar
approach
target
specif
ifni
speci
acut
viral
infect
suppress
detriment
inflamm
without
compromis
viru
clearanc
may
also
possibl
similar
efficaci
may
observ
upon
translat
approach
human
acut
persist
viral
infect
howev
therapi
block
ifni
signal
need
approach
caution
given
delic
balanc
act
requir
control
viru
replic
modul
detriment
immun
respons
jaitin
da
roisman
lc
jak
e
gavuti
piehler
j
van
der
heyden
j
uze
g
schreiber
g
inquir
differenti
action
interferon
ifni
signal
recent
shown
contribut
viral
immun
patholog
elev
ifni
signatur
found
persist
viru
infect
multipl
speci
block
ifni
signal
reduc
immun
system
activ
regulatori
molecul
express
inhibit
ifni
signal
promot
hasten
control
persist
lcmv
infect
target
ifni
signal
viral
infect
may
treat
rang
viral
diseas
